Key Finding
Thread-embedding acupuncture significantly reduced daily urination frequency by approximately 2.5-2.7 episodes in postmenopausal women with overactive bladder, with effects maintained 4 weeks after treatment completion.
Overactive bladder is a common and frustrating condition affecting many women after menopause, causing frequent urination during the day and night that can significantly disrupt daily life. Researchers in this study examined whether a specialized acupuncture technique called thread-embedding acupuncture could help manage these symptoms. This technique involves inserting absorbable threads into acupuncture points, where they provide continuous stimulation over time.
The study followed 20 postmenopausal women with overactive bladder who received thread-embedding acupuncture treatments once weekly for 8 weeks. Participants tracked their bathroom visits using bladder diaries and completed questionnaires about their symptoms and quality of life. Nineteen women completed the full study, and researchers followed up with them 4 weeks after their final treatment.
The results showed promising improvements. Women experienced significant reductions in how often they needed to urinate each day, with an average decrease of about 2.5 to 2.7 bathroom trips daily. Both daytime and nighttime urination frequency improved, and these benefits lasted through the follow-up period. Symptoms scores also decreased significantly. Importantly, no serious side effects were reported during the study.
However, the treatment did not significantly improve feelings of urgency (the sudden strong need to urinate) or actual incontinence episodes. Quality of life scores also didn't show significant changes, though the reduction in bathroom trips likely benefited participants' daily routines and sleep.
While this was a small pilot study without a control group, the findings suggest thread-embedding acupuncture may be a viable option for postmenopausal women struggling with frequent urination. If you're considering this treatment, seek care from a licensed acupuncturist trained in thread-embedding techniques.
This prospective, single-arm study evaluated thread-embedding acupuncture for overactive bladder in postmenopausal women (n=20, 19 completers). Participants received once-weekly treatments for 8 weeks with follow-up at week 12. Primary outcomes included bladder diary parameters, overactive bladder symptom score (OABSS), and King's Health Questionnaire (KHQ).
Results demonstrated statistically significant reductions in average daily micturition frequency at week 8 (-2.55 ± 0.37, P=0.001) and week 12 (-2.69 ± 0.37, P=0.001). Both daytime and nighttime frequency decreased significantly, as did OABSS at both time points. However, urgency episodes, incontinence frequency, and KHQ scores showed no significant improvement. No serious adverse events occurred.
Clinical implications: Thread-embedding acupuncture shows promise for reducing micturition frequency in postmenopausal women with overactive bladder, with sustained effects 4 weeks post-treatment. The lack of improvement in urgency and quality-of-life measures warrants further investigation. Limitations include small sample size, absence of control group, and open-label design. Larger randomized controlled trials are needed to establish efficacy.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.